Virax Biolabs Group Limited (VRAX) Stock Price, Quote & News

Company Profile

Virax Biolabs Group Limited, a biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics. The company offers various in-vitro diagnostics test kits comprising respiratory, pregnancy and fertility, infectious diseases, sti, drugs of abuse, oncology, cardiac, women's health, other test kits under the ViraxClear brands; and rapid and molecular tests for small animal veterinary...

Industry: Biotechnology

Sector: Healthcare

Phone: 44 20 7788 7414

Website: viraxbiolabs.com

Address:

BioCity Glasgow, Bo’Ness Road Newhouse, Lanarkshire, United Kingdom

TopNotchMindset Apr. 25 at 6:58 PM

MITQ 💎Launch starting/Bottom reversal. Low risk play , no dilution, plenty of cash on hand and a small float. Watch for volume next week. MITQ can go big imo. $GMEX $VRAX $LZMH

1 · Reply

SuellenD Apr. 25 at 12:34 AM

$VRAX There's no question in my mind that this stock is going to go up. It's only a matter of time. It's completely undervalued as it is.

0 · Reply

Royal_Imperial Apr. 24 at 9:30 PM

MITQ looking ready, keep eyes on this one. Latest news + contracts rolling in Low float (~sub 10M) NO dilution Record earnings trend 📈. MITQ super undervalued-The entire company trades at 5.5M. It’s sitting on $3.9M in cash. That means you’re effectively buying the entire operating business $18M+ in annual revenue, proprietary products. $TRUG $WHLR $ADTX $VRAX .121

0 · Reply

Yung_Ball3R Apr. 24 at 5:36 PM

$VRAX

0 · Reply

TheWatchGuy0324 Apr. 24 at 5:10 PM

$GMEX if you didn't sell in .50s high .40s with a .38 average them you played this wrong lol. Move over to $VRAX or$LZMH to make more money! $VRAX is a sleeper play/low float. $LZMH is gaining momentum and slowly inching up.

0 · Reply

TheWatchGuy0324 Apr. 24 at 3:55 PM

$LZMH when this runs , i will buy even more $VRAX .

0 · Reply

TheWatchGuy0324 Apr. 24 at 2:27 PM

$VRAX still my favorite play, the float is so low it can explode at any time. This one of those, wake up and the price doubled plays. My opinion

0 · Reply

Emergency123 Apr. 24 at 1:45 PM

$VRAX $CMND $GAME lets GO Barchart # 4 on the hot stocks on the move Things have changed for the good at CNBX with new law change. Game ON, Get eyes here GLTA

0 · Reply

Joshr1371 Apr. 24 at 1:44 PM

$VRAX Phase 2: Quiet accumulation Higher lows forming Volume slowly increasing Less downside follow-through This is where: Smart money starts building

0 · Reply

Joshr1371 Apr. 24 at 1:03 PM

$VRAX They’re positioning the company as undervalued vs cash + pipeline

0 · Reply

Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders

Mar 31, 2026, 10:38 AM EDT - 25 days ago

What's Behind The Jump In Virax Biolabs Stock?

Mar 31, 2026, 7:34 AM EDT - 25 days ago

Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation

Dec 4, 2025, 4:05 PM EST - 5 months ago

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement

Dec 3, 2025, 1:53 PM EST - 5 months ago

Virax Biolabs Group Limited Announces $5 Million Private Placement

Dec 3, 2025, 7:34 AM EST - 5 months ago

Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders

Nov 3, 2025, 8:29 AM EST - 6 months ago

Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes

Aug 26, 2025, 7:30 AM EDT - 8 months ago

Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September

Jul 29, 2025, 7:35 AM EDT - 9 months ago

Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy

Jul 18, 2025, 4:15 PM EDT - 10 months ago

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Mar 31, 2025, 2:57 PM EDT - 1 year ago

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating

Mar 18, 2025, 7:30 AM EDT - 1 year ago

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Mar 13, 2025, 7:30 AM EDT - 1 year ago

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Mar 5, 2025, 7:30 AM EST - 1 year ago

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Feb 25, 2025, 7:00 AM EST - 1 year ago

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Jan 23, 2025, 3:35 PM EST - 1 year ago

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

COSM

Jan 13, 2025, 9:20 AM EST - 1 year ago

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

COSM

Dec 17, 2024, 7:30 AM EST - 1 year ago

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Dec 10, 2024, 7:30 AM EST - 1 year ago

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Oct 23, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Sep 16, 2024, 8:30 AM EDT - 1 year ago

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

COSM

Sep 16, 2024, 8:30 AM EDT - 1 year ago

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

COSM

Sep 9, 2024, 8:00 AM EDT - 1 year ago

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Aug 29, 2024, 9:03 AM EDT - 1 year ago

Virax Biolabs to Participate at 7th European Congress of Immunology

Aug 28, 2024, 2:18 PM EDT - 1 year ago

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know

Aug 28, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Aug 23, 2024, 4:09 PM EDT - 1 year ago

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 9:30 PM EDT - 1 year ago

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 10:20 AM EDT - 1 year ago

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

COSM

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Apr 16, 2024, 7:30 AM EDT - 2 years ago

Virax Biolabs to Participate at ESCMID Global 2024

Dec 21, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Dec 14, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Sep 12, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Sep 1, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Aug 3, 2023, 7:30 AM EDT - 2 years ago

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Jul 18, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

May 4, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

Apr 19, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Mar 10, 2023, 5:17 PM EST - 3 years ago

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 8, 2023, 8:55 AM EST - 3 years ago

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 7, 2023, 7:30 AM EST - 3 years ago

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Feb 7, 2023, 9:15 AM EST - 3 years ago

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

COSM

Feb 7, 2023, 8:30 AM EST - 3 years ago

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

COSM

Feb 6, 2023, 4:05 PM EST - 3 years ago

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Jan 4, 2023, 7:30 AM EST - 3 years ago

Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

Dec 6, 2022, 7:30 AM EST - 3 years ago

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Nov 15, 2022, 7:30 AM EST - 3 years ago

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Nov 8, 2022, 4:30 PM EST - 3 years ago

Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement

Nov 4, 2022, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Announces $3.8 Million Private Placement

TopNotchMindset Apr. 25 at 6:58 PM

MITQ 💎Launch starting/Bottom reversal. Low risk play , no dilution, plenty of cash on hand and a small float. Watch for volume next week. MITQ can go big imo. $GMEX $VRAX $LZMH

1 · Reply

SuellenD Apr. 25 at 12:34 AM

$VRAX There's no question in my mind that this stock is going to go up. It's only a matter of time. It's completely undervalued as it is.

0 · Reply

Royal_Imperial Apr. 24 at 9:30 PM

0 · Reply

Yung_Ball3R Apr. 24 at 5:36 PM

$VRAX

0 · Reply

TheWatchGuy0324 Apr. 24 at 5:10 PM

0 · Reply

TheWatchGuy0324 Apr. 24 at 3:55 PM

$LZMH when this runs , i will buy even more $VRAX .

0 · Reply

TheWatchGuy0324 Apr. 24 at 2:27 PM

$VRAX still my favorite play, the float is so low it can explode at any time. This one of those, wake up and the price doubled plays. My opinion

0 · Reply

Emergency123 Apr. 24 at 1:45 PM

$VRAX $CMND $GAME lets GO Barchart # 4 on the hot stocks on the move Things have changed for the good at CNBX with new law change. Game ON, Get eyes here GLTA

0 · Reply

Joshr1371 Apr. 24 at 1:44 PM

$VRAX Phase 2: Quiet accumulation Higher lows forming Volume slowly increasing Less downside follow-through This is where: Smart money starts building

0 · Reply

Joshr1371 Apr. 24 at 1:03 PM

$VRAX They’re positioning the company as undervalued vs cash + pipeline

0 · Reply

GenX_Forever_Feral Apr. 24 at 12:48 PM

$VRAX I’m not sure what you people have been up to since Wednesday, but I’m thoroughly enjoying this. It’s always better to arrive early and wait than to be late and chase. 💎💎💎🤑🤑🤑🥷🥷🥷

0 · Reply

BestSwing888 Apr. 24 at 11:46 AM

$VRAX here we go

0 · Reply

BiotechGoldenEra Apr. 24 at 4:13 AM

$VRAX new Covid test out soon

0 · Reply

TheWatchGuy0324 Apr. 23 at 8:11 PM

$VRAX very nice close.

0 · Reply

FillSniper42 Apr. 23 at 7:46 PM

IQST is bottomed out with an upcoming product launch and severely undervalued.. - No dilution - $300M+ yearly revenue with 1B+ forecasted for 2027 - $18 Price Target by litchfield (currently trading under $2) $LUNR $NVO $VRAX $GOVX Watch these

0 · Reply

TheWatchGuy0324 Apr. 23 at 6:19 PM

$VRAX consolidation may be done , trying to push up again.

0 · Reply

CrystalTrendLab Apr. 23 at 5:18 PM

$VRAX continues to benefit from investor interest in disruptive technology with visible commercial use cases. AI surveillance and remote protection are high-value sectors, and AITX keeps building momentum with autonomous security units offering continuous observation and deterrence.

1 · Reply

TheZymeth Apr. 23 at 5:11 PM

$VRAX will this also be a part of the daily game? 😂

0 · Reply

TheWatchGuy0324 Apr. 23 at 4:40 PM

$VRAX the truth its up over 10 percent on a day where a lot of stocks are still red. So currently very content with my .13 average. Got excited when it touched .1799 before lol .

0 · Reply

GenX_Forever_Feral Apr. 23 at 4:37 PM

$VRAX RELEASE THE McCRACKEN!

0 · Reply

Yung_Ball3R Apr. 23 at 4:33 PM

$VRAX

0 · Reply

gretaslaps Apr. 23 at 4:27 PM

$VRAX where's @JJBurch

1 · Reply

Market Cap	693,000.00
Revenue (ttm)	10,000.00
Net Income (ttm)	-6.06M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-60,600.00%
Debt to Equity Ratio	0.04

Volume	2,871,000
Avg Vol	15,875,286
Day's Range	N/A - N/A
Shares Out	4.34M
Stochastic %K	64%
Beta	1.61
Analysts	Sell
Price Target	$1.00